Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122554) titled 'AI-Enhanced Doctor-Patient Communication: Development and Evaluation of Behavior Science-Informed LLM Capability Augmentation Technologies' on April 15.
Study Type: Interventional study
Study Design:
Cluster randomization
Primary Sponsor: Tsinghua University, Shenzhen Longhua District People's Hospital
Condition:
Hypertension, type 2 diabetes, chronic obstructive pulmonary disease (COPD), and other common chronic non-communicable diseases (NCDs) in the community.
Intervention:
Intervention Group:Physicians in the intervention group will utilize an LLM-assisted communication system based on behavioral scie...